Research programme: hetero aromatic polycycle antibacterials - Oscient

Drug Profile

Research programme: hetero aromatic polycycle antibacterials - Oscient

Alternative Names: GSQ 10547; GSQ 11203; GSQ 2287; GSQ 5028; GSQ 7302; HARP antibacterials research programme - Oscient; Hetero aromatic polycycle antibacterials research programme - Oscient

Latest Information Update: 24 Nov 2004

Price : $50

At a glance

  • Originator Oscient Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action DNA inhibitors; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 24 Nov 2004 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 13 Apr 2004 Genome Therapeutics is now called Oscient Pharmaceuticals
  • 12 Feb 2004 GeneSoft has merged with Genome Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top